Neuromuscular DiseasesNeuromuscular DiseasesНервно-мышечные болезни2222-87212413-0443Publishing House ABV Press14910.17650/2222-8721-2016-6-2-20-26LECTURES AND REVIEWSЛЕКЦИИ И ОБЗОРЫPeripheral nervous system involvement in patients with diabetes mellitusПоражение периферической нервной системы при сахарном диабетеKamchatnovP. R.КамчатновП. Р.
Russian Federation
ChugunovA. V.ЧугуновА. В.
Russian Federation
Evzel’manM. A.ЕвзельманМ. А.
Russian Federation
N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова»1 Ostrovityanova St., Moscow, 117997, RussiaРоссия, 117997, Москва, ул. Островитянова, 1Medical Institute, I.S. Turgenev Orel State UniversityГБОУ ВПО «Орловский государственный университет им. И.С. Тургенева. Медицинский институт»25 Oktyabr’skaya St, Orel, 302028, RussiaРоссия, 302028, Орел, ул. Октябрьская, 25050720166220260507201605072016Copyright ©; 2016, Kamchatnov P.R., Chugunov A.V., Evzel’man M.A.Copyright ©; 2016, Камчатнов П.Р., Чугунов А.В., Евзельман М.А.2016Kamchatnov P.R., Chugunov A.V., Evzel’man M.A.Камчатнов П.Р., Чугунов А.В., Евзельман М.А.https://creativecommons.org/licenses/by/4.0https://nmb.abvpress.ru/jour/article/view/149

Diabetes mellitus is a widespread disease often affecting peripheral nervous system. This include diabetic autonomous neuropathy that can endanger the patient's life. Timely detection of complications of diabetes mellitus as well as its adequate therapy can improve prognosis of the disease. The possibilities of Milgamma and Tiogamma for pathogenic therapy in patients with diabetic polyneuropathy are considered in this paper. Gabagamma can be effectively relieve neuropathic pain and used together with other drugs that normalize nerve tissue metabolism.

Сахарный диабет – распространенное заболевание, часто приводящее к поражению периферической нервной системы. Опасность представляет вегетативная диабетическая полинейропатия, способная создавать угрозу для жизни пациента. Своевременное выявление осложнений сахарного диабета и адекватная терапия способны улучшить прогноз заболевания. Рассматриваются возможности применения препаратов Мильгамма и Тиогамма для патогенетической терапии пациентов с диабетической полинейропатией. Для купирования нейропатического болевого синдрома эффективно применение Габагаммы, одновременно с которой следует назначать препараты, нормализующие метаболизм нервной ткани.

diabetes mellitusdiabetic neuropathyautomomous polyneuropathycyanocobalaminthiaminebenfotiamineMilgammaTiogammagabapentinGabagammaсахарный диабетдиабетическая полинейропатиявегетативная полинейропатияцианокобаламинтиаминбенфотиаминМильгаммаТиогаммагабапентинГабагамма1. Visser N., Notermans N., Linssen R. et al. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurology 2015;84;3:259–64. DOI: 10.1212/WNL.0000000000001160. PMID: 25503982.Visser N., Notermans N., Linssen R. et al. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurology 2015;84;3:259–64. DOI: 10.1212/WNL.0000000000001160. PMID: 25503982.2. Vincent A., Calabek B., Roberts L., Feldman E. Biology of diabetic neuropathy. Handb Clin Neurol 2013;115:591–606. DOI: 10.1016/B978-0-444-52902-2.00034-5. PMID: 23931804.Vincent A., Calabek B., Roberts L., Feldman E. Biology of diabetic neuropathy. Handb Clin Neurol 2013;115:591–606. DOI: 10.1016/B978-0-444-52902-2.00034-5. PMID: 23931804.3. Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep 2012;12(4):376–83. DOI: 10.1007/s11892- 012-0278-3. PMID: 22562652.Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep 2012;12(4):376–83. DOI: 10.1007/s11892- 012-0278-3. PMID: 22562652.4. Koo B. Screening of autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab J 2014;38(5): 346–8. DOI: 10.4093/dmj.2014.38.5.346. PMID: 25349821.Koo B. Screening of autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab J 2014;38(5): 346–8. DOI: 10.4093/dmj.2014.38.5.346. PMID: 25349821.5. Cohen J., Estacio R., Lundgren R. et al. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Autonomic Neuroscience 2003;108 (1–2):73–8. PMID: 14614967.Cohen J., Estacio R., Lundgren R. et al. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Autonomic Neuroscience 2003;108 (1–2):73–8. PMID: 14614967.6. Callaghan B., Hur J., Feldman E. Diabetic neuropathy: one disease or two? Curr Opin Neurol 2012;25(5):536–41. DOI: 10.1097/ WCO.0b013e328357a797. PMID: 22892951.Callaghan B., Hur J., Feldman E. Diabetic neuropathy: one disease or two? Curr Opin Neurol 2012;25(5):536–41. DOI: 10.1097/ WCO.0b013e328357a797. PMID: 22892951.7. Гурьева И.В., Левин О.С. Диабетическая полинейропатия. Consilium medicum 2014; (4):12–6. [Gur’eva I.V., Levin О.S. Diabetic polyneuropathy. Consilium Medicum 2014;(4):12–6. (In Russ.)].Гурьева И.В., Левин О.С. Диабетическая полинейропатия. Consilium medicum 2014; (4):12–6. [Gur’eva I.V., Levin О.S. Diabetic polyneuropathy. Consilium Medicum 2014;(4):12–6. (In Russ.)].8. Duby J., Campbell K., Setter S. et al. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61(2):160–73. PMID: 14750401.Duby J., Campbell K., Setter S. et al. Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004;61(2):160–73. PMID: 14750401.9. Liu K., Dai L., Jean W. Metformin-related vitamin B12 deficiency. Age Ageing 2006;35(2):200–1. PMID: 16495296.Liu K., Dai L., Jean W. Metformin-related vitamin B12 deficiency. Age Ageing 2006;35(2):200–1. PMID: 16495296.10. Mazokopakis E., Starakis I. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract 2012;97(3):359–67. DOI: 10.1016/j.diabres.2012.06.001. PMID: 22770998.Mazokopakis E., Starakis I. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract 2012;97(3):359–67. DOI: 10.1016/j.diabres.2012.06.001. PMID: 22770998.11. Witzel I.I., Jelinek H., Khalaf K. et al. Identifying common genetic risk factors of diabetic neuropathies. Front Endocrinol (Lausanne) 2015;6:88. DOI: 10.3389/ fendo.2015.00088. PMID: 26074879.Witzel I.I., Jelinek H., Khalaf K. et al. Identifying common genetic risk factors of diabetic neuropathies. Front Endocrinol (Lausanne) 2015;6:88. DOI: 10.3389/ fendo.2015.00088. PMID: 26074879.12. Спицина Е.В., Светлова Г.Н., Строков И.А. и др. Ассоциация полиморфных маркеров Т(-365)С гена POLG1, G(-25)A гена ANT1 и G(-605)T гена PEO1 с диабетической полинейропатией при сахарном диабете типа 1. Молекулярная биология 2009;43(2):378–82. [Spitsinа Е.V., Svetlovа G.N., Strokov I.А. et al. Аssociation of polymorphic markers Т(-365)С gene POLG1, G(-25)A gene ANT1 and G(-605)T gene PEO1 with diabetic polyneuropathy at diabetes mellitus type 1. Моlekulyarnaya biologiya = Моlecular Biology 2009;43(2):378–82. (In Russ.)].Спицина Е.В., Светлова Г.Н., Строков И.А. и др. Ассоциация полиморфных маркеров Т(-365)С гена POLG1, G(-25)A гена ANT1 и G(-605)T гена PEO1 с диабетической полинейропатией при сахарном диабете типа 1. Молекулярная биология 2009;43(2):378–82. [Spitsinа Е.V., Svetlovа G.N., Strokov I.А. et al. Аssociation of polymorphic markers Т(-365)С gene POLG1, G(-25)A gene ANT1 and G(-605)T gene PEO1 with diabetic polyneuropathy at diabetes mellitus type 1. Моlekulyarnaya biologiya = Моlecular Biology 2009;43(2):378–82. (In Russ.)].13. Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии. Журнал неврологии и психиатрии им. С.С. Корсакова 2004;(2):73–80. [Gusev Е.I., Kamchatnov P.R. Normal and pathologic brain plasticity. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neuropathology and Psychiatry 2004;(2):73–80. (In Russ.)].Гусев Е.И., Камчатнов П.Р. Пластичность головного мозга в норме и патологии. Журнал неврологии и психиатрии им. С.С. Корсакова 2004;(2):73–80. [Gusev Е.I., Kamchatnov P.R. Normal and pathologic brain plasticity. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neuropathology and Psychiatry 2004;(2):73–80. (In Russ.)].14. Sadosky A., Schaefer C., Mann R. et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the UC: results of retrospective charts review and crosssectional survey. Diabetes, Metabolic Syndrome and Obesity 2013;6: 79–492.Sadosky A., Schaefer C., Mann R. et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the UC: results of retrospective charts review and crosssectional survey. Diabetes, Metabolic Syndrome and Obesity 2013;6: 79–492.15. Jin H.Y., Baek H.S., Park T.S. Morphologic changes in autonomic nerves in diabetic autonomic neuropathy. Diabetes Metab J 2015;39(6):461–7. DOI: 10.4093/ dmj.2015.39.6.461. PMID 26706915.Jin H.Y., Baek H.S., Park T.S. Morphologic changes in autonomic nerves in diabetic autonomic neuropathy. Diabetes Metab J 2015;39(6):461–7. DOI: 10.4093/ dmj.2015.39.6.461. PMID 26706915.16. Freccero C., Svensson H., Bornmyr S. et al. Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients. Diabetes Care 2004;27(12):2936–41. PMID: 15562210.Freccero C., Svensson H., Bornmyr S. et al. Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients. Diabetes Care 2004;27(12):2936–41. PMID: 15562210.17. Karayannis G., Giamouzis G., Cokkinos D. et al. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther 2012;10(6):747–65. DOI: 10.1586/erc.12.53. PMID: 22894631.Karayannis G., Giamouzis G., Cokkinos D. et al. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther 2012;10(6):747–65. DOI: 10.1586/erc.12.53. PMID: 22894631.18. Boudina S., Abel E. Diabetic cardiomyopathy revisited. Circulation 2007;115(25):3213–23. PMID: 17592090.Boudina S., Abel E. Diabetic cardiomyopathy revisited. Circulation 2007;115(25):3213–23. PMID: 17592090.19. Gatopoulou A., Papanas N., Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med 2012;23(6):499–505. DOI: 10.1016/j.ejim.2012.03.001. PMID: 22863425.Gatopoulou A., Papanas N., Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med 2012;23(6):499–505. DOI: 10.1016/j.ejim.2012.03.001. PMID: 22863425.20. Борискина Л.М. Эффективность Актовегина при лечении заболеваний центральной и периферической нервной системы. Нервно-мышечные болезни 2015;5(2):25–31. DOI:10.17650/2222-8721-2015-5-2-25-31. [Boriskinа L.М. Actovegin efficiency in the treatment of central and peripheral nervous system diseases. Nervnomyshechnye bolezni = Neuro-Muscular Diseases 2015;5(2):25–31. DOI:10.17650/2222-8721-2015-5-2-25-31. (In Russ.)].Борискина Л.М. Эффективность Актовегина при лечении заболеваний центральной и периферической нервной системы. Нервно-мышечные болезни 2015;5(2):25–31. DOI:10.17650/2222-8721-2015-5-2-25-31. [Boriskinа L.М. Actovegin efficiency in the treatment of central and peripheral nervous system diseases. Nervnomyshechnye bolezni = Neuro-Muscular Diseases 2015;5(2):25–31. DOI:10.17650/2222-8721-2015-5-2-25-31. (In Russ.)].21. Scott J., Molloy A. The discovery of vitamin B(12). Ann Nutr Metab 2012;61(3):239–45. DOI: 10.1159/000343114. PMID: 23183296.Scott J., Molloy A. The discovery of vitamin B(12). Ann Nutr Metab 2012;61(3):239–45. DOI: 10.1159/000343114. PMID: 23183296.22. Stracke H., Gaus W., Achenbach U. et al. Benfotiamine in diabetic polyneuropathy (bendip): results of a randomised, doubleblind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 2008;116(10):600–5. DOI: 10.1055/s-2008-1065351. PMID: 18473286.Stracke H., Gaus W., Achenbach U. et al. Benfotiamine in diabetic polyneuropathy (bendip): results of a randomised, doubleblind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 2008;116(10):600–5. DOI: 10.1055/s-2008-1065351. PMID: 18473286.23. Садеков Р.А., Данилов А.Б., Вейн А.М. Лечение диабетической полинейропатии препаратом мильгамма. Журнал неврологии и психиатрии им. С.С. Корсакова 1998; (9):30–2. [Sadekov R.А., Danilov А.B., Veyn А.М. Treatment of diabetic polyneuropathy with milgamma. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neuropathology and Psychiatry 1998;(9):30–2. (In Russ.)].Садеков Р.А., Данилов А.Б., Вейн А.М. Лечение диабетической полинейропатии препаратом мильгамма. Журнал неврологии и психиатрии им. С.С. Корсакова 1998; (9):30–2. [Sadekov R.А., Danilov А.B., Veyn А.М. Treatment of diabetic polyneuropathy with milgamma. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neuropathology and Psychiatry 1998;(9):30–2. (In Russ.)].24. Воробьев С.В., Кириченко Д.А., Ростов И.А. Диагностика и лечение вегетативной дисфункции у больных с метаболическим синдромом и нарушениями углеводного обмена. Лечащий врач 2009;(1):23–9. [Vorob’ev S.V., Kirichenko D.А., Rostov I.А. Diagnosis and treatment of vegetative dysfunction at patients with metabolic syndrome and carbohydrate metabolism dysfunctions. Lechashchiy vrach = Assistant Physician 2009;(1):23–9. (In Russ.)].Воробьев С.В., Кириченко Д.А., Ростов И.А. Диагностика и лечение вегетативной дисфункции у больных с метаболическим синдромом и нарушениями углеводного обмена. Лечащий врач 2009;(1):23–9. [Vorob’ev S.V., Kirichenko D.А., Rostov I.А. Diagnosis and treatment of vegetative dysfunction at patients with metabolic syndrome and carbohydrate metabolism dysfunctions. Lechashchiy vrach = Assistant Physician 2009;(1):23–9. (In Russ.)].25. Rocamonde B., Paradells S., Barcia J. et al. Neuroprotection of lipoic acid treatment promotes angiogenesis and reduces the glial scar formation after brain injury. Neuroscience 2012;224:102–15. DOI: 10.1016/j. neuroscience.2012.08.028. PMID: 22917609.Rocamonde B., Paradells S., Barcia J. et al. Neuroprotection of lipoic acid treatment promotes angiogenesis and reduces the glial scar formation after brain injury. Neuroscience 2012;224:102–15. DOI: 10.1016/j. neuroscience.2012.08.028. PMID: 22917609.26. Tesfaye S., Boulton A., Dickenson A. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 2013;36(9):2456–65. DOI: 10.2337/dc12-1964. PMID: 23970715.Tesfaye S., Boulton A., Dickenson A. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 2013;36(9):2456–65. DOI: 10.2337/dc12-1964. PMID: 23970715.27. Okuyucu S., Kocer A., Eryilmaz M., Kocaman G. Thioctacid is effective for neuropathy symptoms and hyperglycemia control without pronounced electromyographic changes. Neurosciences (Riyadh) 2012;17(4):384–6. PMID: 23022909.Okuyucu S., Kocer A., Eryilmaz M., Kocaman G. Thioctacid is effective for neuropathy symptoms and hyperglycemia control without pronounced electromyographic changes. Neurosciences (Riyadh) 2012;17(4):384–6. PMID: 23022909.28. Taylor C. Mechanisms of action of gabapentin. Rev Neurol (Paris) 1997;153 (Supp l):S39–45. PMID: 9686247.Taylor C. Mechanisms of action of gabapentin. Rev Neurol (Paris) 1997;153 (Supp l):S39–45. PMID: 9686247.29. Backonja M., Beydoun A., Edwards K. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280(21):1831–6.Backonja M., Beydoun A., Edwards K. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280(21):1831–6.30. Rowbotham M., Harden N., Stacey B. et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280(21):1837–42. PMID: 9846778.Rowbotham M., Harden N., Stacey B. et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280(21):1837–42. PMID: 9846778.31. Hempenstall K., Nurmikko T., Johnson R. et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine 2005;2(7):164–9. PMID: 16013891.Hempenstall K., Nurmikko T., Johnson R. et al. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Medicine 2005;2(7):164–9. PMID: 16013891.